Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision label updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a minor site update that does not alter the study information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays Revision: v3.6.3 in the footer, updating from v3.6.2 to v3.6.3. This indicates a maintenance/version update rather than changes to the study content.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a small site update without changing the study details or related content.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded explicit recruitment status ('No longer looking for participants') and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Removed the 'Intervention / Treatment' heading and updated the revision label from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check63 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a minor site update to the interface and does not change study data or page content.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, replacing the previous revision. This reflects a minor update to the page's revision history and metadata.SummaryDifference0.1%

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.